The global cancer vaccine market size was estimated at USD 9.93 billion in 2025 and is projected to reach USD 23.31 billion by 2033, growing at a CAGR of 11.30% from 2026 to 2033. This growth is primarily driven by the rising global burden of cancer, increasing adoption of immunotherapy-... Read More »
January 2026The global meningococcal vaccines market size was estimated at USD 4.05 billion in 2025 and is projected to reach USD 5.96 billion by 2033, growing at a CAGR of 4.5% from 2026 to 2033. The increasing prevalence of meningitis is one of the major factors expected to drive the market. Accor... Read More »
January 2026The global human growth hormone market size was estimated at USD 7.52 billion in 2025 and is projected to reach USD 28.41 billion by 2040, growing at a CAGR of 8.52% from 2026 to 2040. The main reason for the high demand of human growth hormone is adult hormone deficiency, especially Gro... Read More »
January 2026The global generic pharmaceuticals market size was estimated at USD 454.7 billion in 2025 and is projected to reach USD 770.0 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. The growth can be attributed to the constant increase in the number of ANDA approvals and generic dr... Read More »
January 2026The U.S. complementary and alternative medicine market size was estimated at USD 52.78 billion in 2025 and is projected to reach USD 375.51 billion by 2033, growing at a CAGR of 27.8% from 2026 to 2033. The market growth can be attributed to the increasing prevalence of chronic diseases,... Read More »
January 2026The global brachytherapy market size was estimated at USD 1,112.97 million in 2025 and is projected to reach USD 1,967.19 million by 2033, growing at a CAGR of 7.4% from 2026 to 2033. The increasing prevalence of cancer, technological advancements, and a significant rise in the adoption ... Read More »
January 2026The global complementary and alternative medicine market size was estimated at USD 222.62 billion in 2025 and is projected to reach USD 1,430.70 billion by 2033, growing at a CAGR of 26.4% from 2026 to 2033. Growing awareness regarding complementary and alternative medicine (CAM), increa... Read More »
January 2026The global nutritional supplements market size was estimated at USD 517.09 billion in 2025 and is projected to reach USD 862.51 billion by 2033, growing at a CAGR of 6.62% from 2026 to 2033. Market growth is driven by rising health awareness, increasing demand for preventive healthcare, ... Read More »
January 2026The global anti-aging supplements market was valued at USD 4.78 billion in 2025 and is anticipated to reach USD 9.06 billion by 2033, growing at a CAGR of 8.49% from 2026 to 2033. The market for anti-aging supplements has grown significantly due to factors such as rising consumer awarene... Read More »
January 2026The global branded generics market size was estimated at USD 276.98 billion in 2025 and is projected to reach USD 453.05 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. The market continues to be shaped by strong demand in emerging economies, where prescription behavior fav... Read More »
January 2026The global biosimilars market size was estimated at USD 39.59 billion in 2025 and is projected to reach USD 151.58 billion by 2033, growing at a CAGR of 18.44% from 2026 to 2033. The cost-effectiveness of biosimilar drugs and the prevalence of chronic disorders globally are major factors... Read More »
January 2026The global radiotheranostics market size was estimated at USD 11.79 billion in 2025 and is projected to reach USD 25.56 billion by 2033, growing at a CAGR of 9.5% from 2026 to 2033. The market represents a precision medicine approach that integrates molecular imaging with targeted radion... Read More »
January 2026The global glioblastoma multiforme treatment market size was estimated at USD 4.04 billion in 2025 and is projected to reach USD 7.87 billion by 2033, growing at a CAGR of 8.69% from 2026 to 2033. The rising prevalence of Glioblastoma Multiforme (GBM) and its significant clinical burden ... Read More »
January 2026The global vaccine adjuvants market size was estimated at USD 3.94 billion in 2025 and is projected to reach USD 5.96 billion by 2033, growing at a CAGR of 5.60% from 2026 to 2033. The growth of the market is driven by the increasing demand for effective vaccines to combat emerging and r... Read More »
January 2026The global immunotherapy drugs market size was estimated at USD 285.73 billion in 2025 and is expected to reach USD 675.98 billion by 2033, growing at a CAGR of 11.41% from 2026 to 2033. This market is primarily driven by the rising incidence of chronic diseases globally. This market was... Read More »
January 2026The global osteoarthritis therapeutics market size was estimated at USD 5.49 billion in 2025 and is projected to reach USD 10.89 billion by 2033, growing at a CAGR of 8.88% from 2026 to 2033. The osteoarthritis (OA) treatment market is witnessing significant growth, driven by the increas... Read More »
January 2026The global drug discovery outsourcing market size was estimated at USD 8.08 billion in 2025 and is projected to reach USD 17.11 billion by 2033, growing at a CAGR of 10.0% from 2026 to 2033. The market growth is driven by increasing drug development activities, the growing complexity of ... Read More »
January 2026The global biopharmaceutical excipients market size was estimated at USD 3.18 billion in 2025 and is projected to reach USD 4.97 billion by 2033, growing at a CAGR of 5.79% from 2026 to 2033. The industry is growing due to the rapid expansion of biologic drugs such as monoclonal antibodi... Read More »
January 2026The global central nervous system therapeutics market size was estimated at USD 138.59 billion in 2025 and is projected to reach USD 273.32 billion by 2033, growing at a CAGR of 9.1% from 2026 to 2033. The central nervous system (CNS) therapeutics market is experiencing robust growth, dr... Read More »
January 2026The global antifungal drugs market size was estimated at USD 16.93 billion in 2025 and is projected to reach USD 23.39 billion by 2033, growing at a CAGR of 4.19% from 2026 to 2033. The market is driven by the increasing prevalence of fungal infections, particularly among immunocompromis... Read More »
January 2026